(UroToday.com) At the American Urological Association (AUA)’s Drug Development in non-muscle-invasive bladder cancer (NMIBC) From Scientific, Regulatory, Clinician, and Patient Perspectives 2021 virtual meeting included a presentation by Dr. Max Kates discussing predictors for response to BCG therapy.